Jagpal Sukhi

CIK 00015545913 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001554591

Recent Transactions

41 trades

Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2026-06-05+10,000→ 10,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2025-12-23+1,500→ 1,500 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2025-06-06+50,000→ 50,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (Right to Buy)
2024-08-08+28,959→ 28,959 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (Right to Buy)
2024-08-08+35,000→ 35,000 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−5,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−94,113→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−49,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−5,887→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−30,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−50,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−1,750→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−4,200→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−3,859→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−1,218→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−4,509→ 0 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-06-17+12,250→ 12,250 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-03-14+50,000→ 50,000 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-01-28+12,250→ 12,250 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2021-03-15+30,000→ 30,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2020-08-12+5,887→ 5,887 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2020-02-25+94,113→ 94,113 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2019-03-04+200,000→ 200,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2018-03-06+180,360→ 180,360 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2017-03-06+70,000→ 70,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2016-09-30+168,000→ 168,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2016-03-08+48,750→ 48,750 total
Award
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2013-07-15+100,000→ 100,000 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2013-05-14−10,000→ 0 total
Sale
NOVELION THERAPEUTICS INC.
Common stock
2013-05-14$7.96/sh−100→ 1,200 total
Sale
NOVELION THERAPEUTICS INC.
Common stock
2013-05-14$7.95/sh−9,900→ 1,300 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common stock
2013-05-14$7.12/sh+10,000→ 11,200 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2012-08-03−20,000→ 0 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2012-08-03−15,000→ 0 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2012-08-03−12,000→ 0 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Employee Stock Options (right to buy)
2012-08-03−20,000→ 0 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common stock
2012-08-03$3.74/sh+20,000→ 21,200 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common stock
2012-08-03$2.44/sh+15,000→ 36,200 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common stock
2012-08-03$6.28/sh+12,000→ 48,200 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common stock
2012-08-03$7.21/sh+20,000→ 68,200 total
Sale
NOVELION THERAPEUTICS INC.
Common stock
2012-08-03$8.19/sh−67,000→ 1,200 total

Companies

Recent Filings

Address

C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov